ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,442Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 559

$932K Total Retail Price of All Prescriptions

Rank: 3 out of 559

690 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 690 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 13,958 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 861 795 1 2
SIMVASTATIN 580 545 2 3
OMEPRAZOLE 573 493 3 4
TAMSULOSIN HCL 541 525 4 25
LISINOPRIL 484 415 5 1
METFORMIN HCL 427 388 6 5
HYDROCODONE-ACETAMINOPHEN 412 305 S3 7 7
ALENDRONATE SODIUM 401 379 8 13
FUROSEMIDE 370 326 9 11
GLIMEPIRIDE 309 241 10 53
POTASSIUM CHLORIDE 260 237 11 23
AMLODIPINE BESYLATE 235 196 12 6
METOPROLOL TARTRATE 234 211 13 12
ZOLPIDEM TARTRATE 224 169 14 17
PRAVASTATIN SODIUM 206 168 15 35
FINASTERIDE 198 189 16 59
FAMOTIDINE 187 159 17 93
ALLOPURINOL 184 132 18 34
METOPROLOL SUCCINATE 182 173 19 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 163 20 18
HYDROCHLOROTHIAZIDE 170 155 21 8
GABAPENTIN 163 115 22 9
ATORVASTATIN CALCIUM 163 141 22 20
CYMBALTA 156 98 24 78
NEXIUM 153 99 25 57
CARVEDILOL 148 102 26 38
WARFARIN SODIUM 147 128 27 24
DONEPEZIL HCL 147 147 27 36
CITALOPRAM HBR 145 121 29 21
LOSARTAN-HYDROCHLOROTHIAZIDE 138 117 30 52
LOSARTAN POTASSIUM 132 121 31 14
PREDNISONE 130 115 32 49
ATENOLOL 125 110 33 15
ACETAMINOPHEN-CODEINE 123 121 S3 34 83
CIPROFLOXACIN HCL 122 112 35 60
CRESTOR 119 119 36 33
DIOVAN 117 106 37 55
JANUMET 116 72 38 169
SERTRALINE HCL 115 104 39 19
TRAMADOL HCL 100 70 40 27
PAROXETINE HCL 99 68 41 48
ISOSORBIDE MONONITRATE ER 96 85 42 120
FLUTICASONE PROPIONATE 91 80 43 22
AVODART 86 86 44 124
CLOPIDOGREL 86 72 44 51
NAMENDA 85 85 46 56
MELOXICAM 84 73 47 42
LOVASTATIN 84 82 47 10
TRIAMTERENE-HCTZ 80 70 49 47
MIRTAZAPINE 79 78 50 61
SYNTHROID 77 77 51 64
PANTOPRAZOLE SODIUM 76 65 52 41
ZETIA 71 71 53 101
LANTUS 71 68 53 40
VENLAFAXINE HCL ER 68 24 55 111
ADVAIR DISKUS 66 58 56 46
AMLODIPINE BESYLATE-BENAZEPRIL 66 41 56 110
SPIRIVA 65 60 58 67
GLIPIZIDE 65 65 58 31
RANITIDINE HCL 64 64 60 26
SINGULAIR 62 45 61 130
PLAVIX 60 53 62 76
PREMARIN 59 56 R 63 97
VOLTAREN 59 54 63 238
PROAIR HFA 58 36 65 29
DIGOXIN 57 50 66 94
OXYCODONE HCL-ACETAMINOPHEN 56 28 S2 67 70
AZITHROMYCIN 55 50 68 39
OXYBUTYNIN CHLORIDE ER 55 55 68 138
OXYCODONE-ACETAMINOPHEN 55 29 S2 68 44
FENTANYL 55 55 S2 68 88
DOXAZOSIN MESYLATE 53 53 72 43
SPIRONOLACTONE 51 31 73 74
TRICOR 51 24 73 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.